Cardiovascular considerations in caring for pregnant patients: a scientific statement from the American Heart Association
Open accessAbstract
Cardio-obstetrics has emerged as an important multidisciplinary field that requires a team approach to the management of cardiovascular disease during pregnancy. Cardiac conditions during pregnancy include hypertensive disorders, hypercholesterolemia, myocardial infarction, cardiomyopathies, arrhythmias, valvular disease, thromboembolic disease, aortic disease, and cerebrovascular diseases. Cardiovascular disease is the primary cause of pregnancy-related mortality in the United States. Advancing maternal age and preexisting comorbid conditions have contributed to the increased rates of maternal mortality. Preconception counseling by the multidisciplinary cardio-obstetrics team is essential for women with preexistent cardiac conditions or history of preeclampsia. Early involvement of the cardio-obstetrics team is critical to prevent maternal morbidity and mortality during the length of the pregnancy and 1 year postpartum. A general understanding of cardiovascular disease during pregnancy should be a core knowledge area for all cardiovascular and primary care clinicians. This scientific statement provides an overview of the diagnosis and management of cardiovascular disease during pregnancy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Support from an interdisciplinary team can be particularly effective for facilitating lifestyle modification and weight loss.
“Support from an interdisciplinary team that may include nutritionists, kinesiologists, pharmacists, and mental health specialists, in addition to obesity medicine specialists, can be particularly effective for facilitating lifestyle modification and weight loss.17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The ‘Hypertensive Disorders in Pregnancy’ section recommends a multidisciplinary strategy that includes lifestyle and behavioral changes such as diet and exercise. It does not say that interdisciplinary support is particularly effective for weight loss, or identify the specialists listed in the citing sentence. (LLM, conf=0.84)
Experimental — accuracy not yet measuredMore timely initiation of therapy is associated with improved cardiovascular clinical outcomes among individuals with hypertension, diabetes, and dyslipidemias.
“More timely initiation of therapy is associated with improved cardiovascular clinical outcomes among individuals with hypertension, diabetes, and dyslipidemias.18,53”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The “Hypertensive Disorders in Pregnancy” section recommends treatment within 30–60 minutes of confirmed severe hypertension to reduce maternal cardiovascular risks. This supports the claim only for severe hypertension in pregnancy; the paper does not establish that earlier therapy improves cardiovascular outcomes for people with diabetes or dyslipidemia. (LLM, conf=0.86)
Experimental — accuracy not yet measuredRecent evidence suggests that counseling related to risk reduction for CKM syndrome in high-risk women should start in the prenatal period and continue until the completion of postpartum follow-up visits for the mother and baby.
“However, recent evidence suggests that counseling related to risk reduction for CKM syndrome in high-risk women should start in the prenatal period and continue until the completion of postpartum follow-up visits for the mother and baby.16–18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The paper’s pre-pregnancy counseling discussion recommends counseling women with cardiovascular disease, and its Clinical Statements and Guidelines section recommends fourth-trimester follow-up, risk-factor modification, and discussion of future cardiovascular risk after adverse pregnancy outcomes (page not available in our copy). It does not specify CKM syndrome risk-reduction counseling or say that counseling should continue until both mother and baby complete postpartum follow-up visits. (LLM, conf=0.84)
Experimental — accuracy not yet measuredDespite the lack of CVD event reduction, lifestyle modification with behavior change, healthy dietary modification, and physical activity, resulting in weight loss of 5% to 10%, causes improvements in CKM risk factors including remission of T2D, with the CKM benefits of lifestyle modification observed across a range of populations and geographic settings.
“Despite the lack of CVD event reduction, lifestyle modification with behavior change, healthy dietary modification, and physical activity, resulting in weight loss of 5% to 10%, causes improvements in CKM risk factors including remission of T2D,17,18 with the CKM benefits of lifestyle modification observed across a range of populations and geographic settings.19”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredDysregulation of pregnancy changes leading to excess insulin resistance, adipose deposition, hypercoagulability, cardiac remodeling, and decreased vascular resistance may result in APOs.
“dysregulation of these changes leading to excess insulin resistance, adipose deposition, hypercoagulability, cardiac remodeling, and decreased vascular resistance,12,18 may result in APOs.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The paper describes left-ventricular structural changes and declining systemic vascular resistance during pregnancy (opening physiology passage; page unavailable), and hypercoagulability during pregnancy (Clinical Statements and Guidelines; page unavailable). It also discusses adverse pregnancy outcomes, but attributes their shared pathways to placental dysfunction and oxidative stress. Our copy does not link dysregulation of the listed changes to APOs or address excess insulin resistance and adipose deposition in that account. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Adverse CKM risk factor levels during the prepregnancy period are associated with increased risk of APOs.
“Adverse CKM risk factor levels (overweight/obesity, hypertension, hypertriglyceridemia, diabetes, CKD) during the prepregnancy period are associated with increased risk of APOs.18,29”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The section on hypertensive disorders in pregnancy identifies chronic hypertension and diabetes as high-risk conditions in the context of preeclampsia prevention. The hypercholesterolemia section links elevated triglycerides during pregnancy—not before pregnancy—to preeclampsia and gestational diabetes. The paper does not establish the claimed prepregnancy association for the full list, particularly overweight/obesity and CKD. (LLM, conf=0.82)
Experimental — accuracy not yet measuredWaist-hip ratio provides improved characterization of metabolic and cardiovascular risk than waist circumference, but challenges of complexity of measurement and lack of standardization make it less ideal for use in clinical settings.
“While waist-hip ratio provides improved characterization of metabolic and cardiovascular risk than waist circumference, challenges of complexity of measurement and lack of standardization make it less ideal for use in clinical settings.18,29–32”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The clinical-statements passages discuss cardiovascular risk in pregnancy, but do not compare waist-hip ratio with waist circumference or discuss measurement complexity and standardization. Searches for both measures and those practical limitations found no relevant passage in our copy. (LLM, conf=0.76)
Experimental — accuracy not yet measuredUsing both BMI and waist circumference provides complementary prognostic information regarding risk for future metabolic derangements, incident CVD, and mortality.
“Using both BMI and waist circumference provides complementary prognostic information regarding risk for future metabolic derangements, incident CVD, and mortality.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Clinical Statements and Guidelines passage links adverse pregnancy outcomes—not combined BMI and waist-circumference measurements—to future CVD risk. Searches for “waist circumference,” “BMI,” and the claimed complementary prognostic value found no passage in our copy addressing that comparison or its prediction of metabolic derangements, incident CVD, and mortality. (LLM, conf=0.78)
Experimental — accuracy not yet measuredRegular assessments of lipids, glycemia, and kidney function are recommended with increasing frequency for higher CKM stages, as the risk for progressive metabolic and kidney disease increases along the CKM spectrum.
“Regular assessments of lipids, glycemia, and kidney function (eg, eGFR) are recommended with increasing frequency for higher CKM stages, as the risk for progressive metabolic and kidney disease increases along the CKM spectrum.13,18–21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Hypercholesterolemia in Pregnancy section (p. e889) discusses baseline lipid testing and screening before pregnancy, not surveillance by CKM stage. Searches for CKM stages and eGFR monitoring found no passage recommending increasingly frequent assessments of lipids, glycemia, and kidney function across the CKM spectrum. (LLM, conf=0.75)
Experimental — accuracy not yet measuredThrough these mechanisms, adverse SDOH lead to CKM risk factor development.
“Through these mechanisms, adverse SDOH lead to CKM risk factor development.16–20”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Clinical Statements and Guidelines passage (page not available) links adverse pregnancy outcomes—not adverse social determinants of health (SDOH)—to later cardiovascular risk. Searches for SDOH, social determinants of health, and socioeconomic status found no passage connecting adverse SDOH to the development of cardiovascular-kidney-metabolic (CKM) risk factors through the claimed mechanisms. (LLM, conf=0.75)
Experimental — accuracy not yet measuredModest weight loss of 5% to 10% among patients with overweight or obesity and diabetes is associated with improvement in glycemic measures, BP, HDL-C, and triglycerides, and can reduce risk for incident CKM risk factors such as diabetes and hypertension.
“Modest weight loss of 5% to 10% among patients with overweight or obesity and diabetes is associated with improvement in glycemic measures, BP, HDL-C, and triglycerides, among others. This can result in risk reduction for incident CKM risk factors such as diabetes and hypertension.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredAverage excess weight loss is greater with RYGB (56%) than LSG (46%).
“Average excess weight loss is greater with RYGB (56%) than LSG (46%),2,18 with persistent differences at 10 years.4”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Hypercholesterolemia in Pregnancy section discusses weight management in general, but does not compare bariatric procedures. Searches for RYGB, LSG, gastric bypass, sleeve gastrectomy, and the 56% and 46% excess-weight-loss figures found no passage in our copy addressing the claim. (LLM, conf=0.76)
Experimental — accuracy not yet measuredBupropion/naltrexone, phentermine/topiramate, and orlistat have shown efficacy in improving glycemia, and phentermine/topiramate and orlistat in reducing BP.
“Bupropion/naltrexone, phentermine/topiramate, and orlistat have all shown efficacy in improving glycemia, and the latter 2, in reducing BP.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Hypercholesterolemia in Pregnancy passage (p. e889) discusses lipid-lowering treatment during pregnancy, while the hypertensive-disorders passage discusses blood-pressure treatment; neither addresses the claimed effects of these weight-loss drugs. Searches for bupropion, phentermine, orlistat, and glycemic and blood-pressure effects found no passage supporting the claim. (LLM, conf=0.78)
Experimental — accuracy not yet measuredClinical trials have indicated a lack of heterogeneity in the effects of each class of these cardioprotective glucose-lowering therapies between those who were and were not taking the other agent.
“Clinical trials have indicated a lack of heterogeneity in the effects of each class of these cardioprotective glucose-lowering therapies between those who were and were not taking the other agent.17–19,21”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The cited statement addresses cardiovascular care during pregnancy; its Clinical Statements and Guidelines section discusses antihypertensive trials in pregnant women, not trials comparing the effects of cardioprotective glucose-lowering therapies by use of another agent. Searches for the claimed lack of heterogeneity and for concomitant glucose-lowering therapy found no passage addressing that comparison. (LLM, conf=0.77)
Experimental — accuracy not yet measuredIn patients with symptomatic PAD, semaglutide increases walking distance.
“In patients with symptomatic PAD, semaglutide increases walking distance.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The passages from Hypercholesterolemia in Pregnancy (p. e889) discuss lipid-lowering treatment during pregnancy, while the other retrieved passages concern pregnancy-related cardiovascular care. Searches for semaglutide, symptomatic PAD, and walking distance found no passage addressing the claimed effect. (LLM, conf=0.78)
Experimental — accuracy not yet measuredTreatment of obesity-related HFpEF with the GLP-1-based therapies semaglutide and tirzepatide achieves improvements in HF patient-reported health status and quality of life, functional capacity as measured by the 6-minute walk distance (6MWD), and freedom from worsening HF events, including HF hospitalizations.
“Treatment of obesity-related HFpEF with the GLP-1–based therapies semaglutide and tirzepatide achieves improvements in HF patient-reported health status and quality of life, functional capacity as measured by the 6-minute walk distance (6MWD), and freedom from worsening HF events, including HF hospitalizations.1,3,17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Clinical Statements and Guidelines passage discusses treatment of peripartum cardiomyopathy and heart-failure complications during pregnancy, not obesity-related HFpEF. Searches for semaglutide, tirzepatide, 6-minute walk distance, quality of life, and HF hospitalizations found no passage addressing the attributed treatment outcomes. (LLM, conf=0.78)
Experimental — accuracy not yet measuredOne analysis was based on the results of the EMPEROR-PRESERVED trial, in which the effect of SGLT2i on cardiovascular mortality in HFpEF was not statistically significant (HR, 0.91; 95% CI, 0.76-1.09).
“One analysis was based on the results of the EMPEROR-PRESERVED trial, in which the effect of SLGT2i on cardiovascular mortality in HFpEF was not statistically significant (HR, 0.91; 95% CI, 0.76–1.09).”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The clinical-guidance passages concern cardiovascular care during pregnancy, and the references shown concern pregnancy-related heart disease. Searches of our copy for EMPEROR-PRESERVED, SGLT2 inhibitors, and the reported hazard ratio found no passage addressing the trial or its cardiovascular-mortality result. (LLM, conf=0.78)
Experimental — accuracy not yet measuredTwo high-quality simulation model-based cost-effectiveness analyses evaluated the economic value of adding SGLT2i therapy to prior GDMT in adults with symptomatic HFpEF, but neither study reported subgroup analyses by diabetes status.
“Two high-quality simulation model–based cost-effectiveness analyses evaluated the economic value of adding SGLT2i therapy to prior GDMT in adults with symptomatic HFpEF, but neither study reported subgroup analyses by diabetes status.17,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The cited statement concerns cardiovascular care during pregnancy; the passages in its hypertensive-disorders and peripartum-cardiomyopathy sections do not address cost-effectiveness analyses of SGLT2 inhibitors for symptomatic HFpEF. Searches for SGLT2i, HFpEF, economic modeling, and diabetes-status subgroup analyses found no passage addressing the claim. (LLM, conf=0.78)
Experimental — accuracy not yet measuredIn a sensitivity analysis assuming a 9% cardiovascular mortality benefit, the ICER was $174,053 per QALY gained.
“In a sensitivity analysis assuming a 9% cardiovascular mortality benefit, the ICER was $174 053 per QALY gained.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The cited scientific statement discusses cardiovascular care in pregnancy, including contraceptive guidance in Table 2, but the passages found do not report a cost-effectiveness analysis. Searches for the 9% mortality assumption, $174,053, ICER, and QALYs found no supporting passage in our copy. (LLM, conf=0.77)
Experimental — accuracy not yet measuredPrior studies performed using a US health care sector perspective and a lifetime analytic horizon noted that SGLT2i therapy was unlikely to be cost-effective for HFpEF, but that the incremental cost-effectiveness ratio was sensitive to the effect on mortality.
“Prior studies performed using a US health care sector perspective and a lifetime analytic horizon noted that SGLT2i therapy was unlikely to be cost-effective for HFpEF, but that the incremental cost-effectiveness ratio was sensitive to the effect on mortality.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredThese analyses suggest that SGLT2i therapy is not cost-effective at current drug prices (incremental cost-effectiveness ratio ≥$120,000 per QALY gained), but these analyses pooled individuals with and without diabetes, and there may be additional cardiovascular and kidney benefits in individuals with diabetes.
“These analyses suggest that SGLT2i therapy is not cost-effective at current drug prices (incremental cost-effectiveness ratio ≥$120 000 per QALY gained), but these analyses pooled individuals with and without diabetes, and there may be additional cardiovascular and kidney benefits in individuals with diabetes.”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measuredFibrosis stage best predicts adverse outcomes in MASLD.
“Fibrosis stage best predicts adverse outcomes in MASLD.1,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
Our copy discusses cardiovascular risks during pregnancy, including how mitral stenosis severity relates to risk in the Clinical Statements and Guidelines section (page not provided). Searches for fibrosis stage, MASLD, and steatotic liver disease found no passage addressing whether fibrosis predicts adverse outcomes in MASLD. (LLM, conf=0.77)
Experimental — accuracy not yet measuredLower eGFR, higher UACR, and higher CKD stages are associated with VTE development and worse outcomes.
“a lower eGFR, higher UACR, and higher CKD stages are associated with VTE development and worse outcomes.16–20”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The ‘Deep Venous Thrombosis and Pulmonary Embolism in Pregnancy’ section (page unavailable) discusses pregnancy-related VTE risk and outcomes, but does not link them to kidney-function measures. Searches for eGFR, UACR, CKD stage, albuminuria, and related terms found no passage addressing the claimed associations. (LLM, conf=0.76)
Experimental — accuracy not yet measuredWomen planning pregnancy with diabetes are at greater risk of APOs compared to women without diabetes or those who develop GDM.
“Women planning pregnancy with diabetes are at greater risk of experiencing APOs compared to women without diabetes or those who develop GDM.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Clinical Statements and Guidelines section lists gestational diabetes among adverse pregnancy outcomes, but does not compare outcomes in women with preexisting diabetes, gestational diabetes, and no diabetes. Searches for pregestational diabetes and those comparisons found no passage addressing the claimed relative risk; the retrieved passages have no page numbers. (LLM, conf=0.75)
Experimental — accuracy not yet measuredAn effective response to obesity pharmacotherapy has historically been described as at least 5% of body weight loss after 3 months of treatment.
“An effective response to obesity pharmacotherapy has historically been described as at least 5% of body weight loss after 3 months of treatment.18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Hypercholesterolemia in Pregnancy section (p. e889) recommends weight management as part of a heart-healthy lifestyle, but does not define an effective response to obesity medication. Searches for obesity pharmacotherapy, 5% weight loss, and a three-month treatment threshold found no passage addressing the claimed criterion. (LLM, conf=0.76)
Experimental — accuracy not yet measuredMetabolic and bariatric surgery, which induces body weight loss of >20%, improves OSA and is associated with reductions in CV and renal events and in cardiovascular and all-cause mortality among people with OSA.
“MBS, which induces body weight loss of >20%, also improves OSA, and is associated with reductions in CV and renal events, and in cardiovascular and all-cause mortality among people with OSA.3,18”
From 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome (2026) · cites this paper as [18]
The Clinical Statements and Guidelines passage discusses cardiovascular risk after adverse pregnancy outcomes, not metabolic and bariatric surgery or outcomes among people with OSA. Searches of our full-text copy for bariatric surgery, OSA, sleep apnea, and the claimed weight-loss and event reductions found no passage addressing the claim; no page number is available for the cited passage. (LLM, conf=0.76)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Grundy, S. M., Stone, N. J., Bailey, A. L., Beam, C., Birtcher, K. K., Blumenthal, R. S., Braun, L. T., de Ferranti, S., Faiella-Tommasino, J., Forman, D. E., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000625 · Cited by 6,185 · see citing works
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C.-T., Fesmire, F. M., Franklin, B. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182742cf6 · Cited by 4,763 · see citing works
Erbel (2014) · doi:10.1093/eurheartj/ehu281 · Cited by 4,451 · see citing works
Priori, S. G., Blomström-Lundqvist, C., Mazzanti, A., Blom, N., Borggrefe, M., Camm, J., Elliott, P. M., Fitzsimons, D., Hatala, R., Hindricks, G., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv316 · Cited by 3,893 · see citing works
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism
Authors/Task Force Members, Konstantinides, S. V., Torbicki, A., Agnelli, G., Danchin, N., Fitzmaurice, D., Galiè, N., Gibbs, J. S. R., Huisman, M. V., Humbert, M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu283 · Cited by 3,128 · see citing works
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,906 · see citing works
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552 · see citing works
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Fleisher, L. A., Jneid, H. M., Mack, M. J., McLeod, C. J., O’Gara, P. T., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000503 · Cited by 2,506 · see citing works
WRITING GROUP MEMBERS, Hiratzka, L. F., Bakris, G. L., Beckman, J. A., Bersin, R. M., Carr, V. F., Casey, D. E., Eagle, K. A., Hermann, L. K., Isselbacher, E. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3181d4739e · Cited by 2,323 · see citing works
Prognosis of Cerebral Vein and Dural Sinus Thrombosis
Ferro, J. M., Canhão, P., Stam, J., Bousser, M., & Barinagarrementería, F. (2004) · Stroke · doi:10.1161/01.str.0000117571.76197.26 · Cited by 2,309 · see citing works
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy
Regitz-Zagrosek, V., Roos-Hesselink, J. W., Bauersachs, J., Blomström-Lundqvist, C., Cífková, R., De Bonis, M., Iung, B., Johnson, M. R., Kintscher, U., Kranke, P., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy340 · Cited by 2,292 · see citing works
Self-citation2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary
O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., Ettinger, S. M., Fang, J. C.-T., Fesmire, F. M., Franklin, B. A., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182742c84 · Cited by 2,251 · see citing works
Rana (2019) · doi:10.1161/circresaha.118.313276 · Cited by 2,095 · see citing works
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525 · see citing works
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
Curtis, K. M., Tepper, N. K., Jatlaoui, T. C., Berry-Bibee, E., Horton, L. G., Zapata, L. B., Simmons, K. B., Pagano, H. P., Jamieson, D. J., & Whiteman, M. K. (2016) · MMWR. Recommendations and Reports · doi:10.15585/mmwr.rr6503a1 · Cited by 1,456 · see citing works
Hayes, S. N., Kim, E., Saw, J., Adlam, D., Arslanian‐Engoren, C., Economy, K. E., Ganesh, S. K., Gulati, R., Lindsay, M. E., Mieres, J. H., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000564 · Cited by 1,325 · see citing works
Self-citationLabor Induction versus Expectant Management in Low-Risk Nulliparous Women
Grobman, W. A., Rice, M. M., Reddy, U. M., Tita, A., Silver, R. M., Mallett, G. L., Hill, K., Thom, E. A., El-Sayed, Y. Y., Perez‐Delboy, A., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1800566 · Cited by 1,190 · see citing works
Cardiovascular Physiology of Pregnancy
Sanghavi, M., & Rutherford, J. D. (2014) · Circulation · doi:10.1161/circulationaha.114.009029 · Cited by 1,186 · see citing works
Preeclampsia and Future Cardiovascular Health: A Systematic Review and Meta-Analysis
Wu, P., Haththotuwa, R., Kwok, C. S., Babu, A., Kotronias, R. A., Rushton, C., Zaman, A., Fryer, A. A., Kadam, U., Chew-Graham, C. A., et al. (2017) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.116.003497 · Cited by 1,147 · see citing works
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127 · see citing works
Sliwa, K. S., Hilfiker‐Kleiner, D., Petrie, M. C., Mebazaa, A., Pieske, B. M., Buchmann, E., Regitz‐Zagrosek, V., Schaufelberger, M., Tavazzi, L., van Veldhuisen, D. J., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq120 · Cited by 1,094 · see citing works
Amsterdam, E. A., Wenger, N. K., Brindis, R. G., Casey, D. E., Ganiats, T. G., Holmes, D. R., Jaffe, A. S., Jneid, H., Kelly, R. F., Kontos, M. C., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000134 · Cited by 1,059 · see citing works
Tamis‐Holland, J. E., Jneid, H. M., Reynolds, H. R., Agewall, S., Brilakis, E. S., Brown, T. M., Lerman, A., Cushman, M., Kumbhani, D. J., Arslanian‐Engoren, C., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000670 · Cited by 1,023 · see citing works
Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., Howard, V. J., Lichtman, J. H., Lisabeth, L. D., Piña, I. L., et al. (2014) · Stroke · doi:10.1161/01.str.0000442009.06663.48 · Cited by 941 · see citing works
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
Horlocker, T. T., Vandermeulen, E., Kopp, S. L., Gogarten, W., Leffert, L. R., & Benzon, H. T. (2018) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0000000000000763 · Cited by 935 · see citing works
Cardiovascular sequelae of preeclampsia/eclampsia: A systematic review and meta-analyses
McDonald, S. D., Malinowski, A., Zhou, Q., Yusuf, S., & Devereaux, P. J. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.06.042 · Cited by 924 · see citing works
(2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003018 · Cited by 916 · see citing works
Liu, S., Liston, R. M., Joseph, K. S., Heaman, M. I., SAUVE, R. S., Kramer, M. S., & for the Maternal Health Study Group of the Canadian Perinatal Surveillance System (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.060870 · Cited by 873 · see citing works
ACOG Practice Bulletin No. 203: Chronic Hypertension in Pregnancy
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003020 · Cited by 871 · see citing works
Koopmans, C. M., Bijlenga, D., Groen, H., Vijgen, S. M. C., Aarnoudse, J. G., Bekedam, D. J., van den Berg, P. P., de Boer, K., Burggraaff, J. M., Bloemenkamp, K. W. M., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60736-4 · Cited by 791 · see citing works
National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 2
Jacobson, T. A., Maki, K. C., Orringer, C. E., Jones, P. H., Kris-Etherton, P., Sikand, G., La Forge, R., Daniels, S. R., Wilson, D. P., Morris, P. B., et al. (2015) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2015.09.002 · Cited by 784 · see citing works
Spontaneous Coronary Artery Dissection
Saw, J., Aymong, E. D., Sedlak, T., Buller, C. E. H., Starovoytov, A., Ricci, D. R., Robinson, S. S., Vuurmans, T., Gao, M., Humphries, K. H., et al. (2014) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001760 · Cited by 783 · see citing works
Predictors of pregnancy complications in women with congenital heart disease
Drenthen, W., Boersma, E. H., Balci, A., Moons, P., Roos‐Hesselink, J. W., Mulder, B. J. M., Vliegen, H. W., van Dijk, A. P. J., Voors, A. A., Yap, S., et al. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq200 · Cited by 708 · see citing works
Antihypertensive drug therapy for mild to moderate hypertension during pregnancy
Abalos, E., Duley, L., & Steyn, D. W. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002252.pub3 · Cited by 705 · see citing works
Pregnancy Outcomes in Women With Heart Disease
Silversides, C. K., Grewal, J., Mason, J., Sermer, M., Kiess, M. C., Rychel, V., Wald, R. M., Colman, J. M., & Siu, S. C. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.02.076 · Cited by 681 · see citing works
Spontaneous Coronary Artery Dissection
Tweet, M. S., Eleid, M. F., Best, P. J. M., Lennon, R. J., Lerman, A., Rihal, C. S., Holmes, D. R., Hayes, S. N., & Gulati, R. (2014) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001659 · Cited by 631 · see citing works
Bates, S. M., Rajasekhar, A., Middeldorp, S., McLintock, C., Rodger, M. A., James, A. H., Vazquez, S. R., Greer, I. A., Riva, J. J., Bhatt, M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018024802 · Cited by 625 · see citing works
Spontaneous Coronary Artery Dissection
Saw, J., Humphries, K. H., Aymong, E. D., Sedlak, T., Prakash, R., Starovoytov, A., & Mancini, G. B. J. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.06.053 · Cited by 619 · see citing works
Grandi, S. M., Filion, K. B., Yoon, S., Ayele, H. T., Doyle, C. M., Hutcheon, J. A., Smith, G. N., Gore, G. C., Ray, J. G., Nerenberg, K., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.036748 · Cited by 610 · see citing works
von Dadelszen, P., Payne, B. A., Li, J., Ansermino, J. M., Pipkin, F. B., Côté, A., Douglas, M. J., Gruslin, A., Hutcheon, J. A., Joseph, K. S., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61351-7 · Cited by 585 · see citing works
Acute Myocardial Infarction in Pregnancy
James, A., Jamison, M. G., Biswas, M. S., Brancazio, L. R., Swamy, G. K., & Myers, E. R. (2006) · Circulation · doi:10.1161/circulationaha.105.576751 · Cited by 555 · see citing works
Clinical Outcomes for Peripartum Cardiomyopathy in North America
McNamara, D. M., Elkayam, U., Alharethi, R. A., Damp, J. B., Hsich, E., Ewald, G. A., Modi, K. A., Alexis, J. D., Ramani, G. V., Semigran, M. J., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.06.1309 · Cited by 538 · see citing works
ACOG Practice Bulletin No. 196: Thromboembolism in Pregnancy
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002706 · Cited by 515 · see citing works
Physiologic Changes During Normal Pregnancy and Delivery
Ouzounian, J. G., & Elkayam, U. (2012) · Cardiology Clinics · doi:10.1016/j.ccl.2012.05.004 · Cited by 506 · see citing works
Stroke and Severe Preeclampsia and Eclampsia: A Paradigm Shift Focusing on Systolic Blood Pressure
Martin, J. N., Jr., Thigpen, B. D., Moore, R., Rose, C. H., Cushman, J., & May, W. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000151116.84113.56 · Cited by 504 · see citing works
Canobbio, M. M., Warnes, C. A., Aboulhosn, J., Connolly, H. M., Khanna, A. D., Koos, B. J., Mital, S. R., Rose, C. H., Silversides, C. K., & Stout, K. (2017) · Circulation · doi:10.1161/cir.0000000000000458 · Cited by 474 · see citing works
Self-citationACOG Practice Bulletin No. 212: Pregnancy and Heart Disease
(2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003243 · Cited by 457 · see citing works
Risks of contraception and pregnancy in heart disease
Thorne, S., MacGregor, A., & Nelson-Piercy, C. (2006) · Heart · doi:10.1136/hrt.2006.095240 · Cited by 456 · see citing works
Pregnancy-Associated Acute Myocardial Infarction
Elkayam, U., Jalnapurkar, S., Barakkat, M. N., Khatri, N., Kealey, A. J., Mehra, A., & Roth, A. (2014) · Circulation · doi:10.1161/circulationaha.113.002054 · Cited by 450 · see citing works
The effect of valvular heart disease on maternal and fetal outcome of pregnancy
Hameed, A. B., Karaalp, I. S., Tummala, P. P., Wani, O. R., Canetti, M., Akhter, M. W., Goodwin, M., Zapadinsky, N., & Elkayam, U. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01198-0 · Cited by 440 · see citing works
Jeejeebhoy, F. M., Zelop, C. M., Lipman, S., Carvalho, B., Joglar, J. A., Mhyre, J. M., Katz, V. L., Lapinsky, S. E., Einav, S., Warnes, C. A., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000300 · Cited by 428 · see citing works
Self-citationArany, Z. P., & Elkayam, U. (2016) · Circulation · doi:10.1161/circulationaha.115.020491 · Cited by 416 · see citing works
Al-Khatib, S. M., Stevenson, W. G., Ackerman, M. J., Bryant, W. J., Callans, D. J., Curtis, A. B., Deal, B. J., Dickfeld, T., Field, M. E., Fonarow, G. C., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000548 · Cited by 412 · see citing works
Acute myocardial infarction associated with pregnancy
Roth, A., & Elkayam, U. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.049 · Cited by 381 · see citing works
Brown, H. L., Warner, J. J., Gianos, E., Gulati, M., Hill, A. J., Hollier, L. M., Rosen, S. E., Rosser, M. L., & Wenger, N. K. (2018) · Circulation · doi:10.1161/cir.0000000000000582 · Cited by 378 · see citing works
High-Risk Cardiac Disease in Pregnancy
Elkayam, U., Goland, S., Pieper, P. G., & Silversides, C. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.048 · Cited by 375 · see citing works
Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism
van der Pol, L. M., Tromeur, C., Bistervels, I. M., Áinle, F. N., van Bemmel, T., Bertoletti, L., Couturaud, F., van Dooren, Y. P. A., Élias, A., Faber, L. M., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813865 · Cited by 369 · see citing works
Pregnancy in Women With a Mechanical Heart Valve
van Hagen, I. M., Roos‐Hesselink, J. W., Ruys, T. P. E., Merz, W. M., Goland, S., Gabriel, H., Lelonek, M., Trojnarska, O., Almahmeed, W. A., Balint, H. O., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.015242 · Cited by 356 · see citing works
Long QT Syndrome and Pregnancy
Seth, R., Moss, A. J., McNitt, S. A., Zaręba, W., Andrews, M. L., Qi, M., Robinson, J. L., Goldenberg, I., Ackerman, M. J., Benhorin, J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.054 · Cited by 350 · see citing works
Histopathologic findings in human aortic media associated with pregnancy.
Manalo-Estrella, P., & Barker, A. (1967) · PubMed · Cited by 348 · see citing works
Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
Hilfiker‐Kleiner, D., Haghikia, A., Berliner, D., Vogel‐Claussen, J., Schwab, J., Franke, A., Schwarzkopf, M., Ehlermann, P., Pfister, R., Michels, G., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx355 · Cited by 348 · see citing works
The incidence of pregnancy-related stroke: A systematic review and meta-analysis
Swartz, R. H., Cayley, M. L., Foley, N. C., Ladhani, N. N. N., Leffert, L. R., Bushnell, C., McClure, J. A., & Lindsay, M. P. (2017) · International Journal of Stroke · doi:10.1177/1747493017723271 · Cited by 330 · see citing works
Use of Medication for Cardiovascular Disease During Pregnancy
Halpern, D. G., Weinberg, C. R., Pinnelas, R., Mehta‐Lee, S. S., Economy, K. E., & Valente, A. M. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.075 · Cited by 316 · see citing works
Self-citationVenous Thromboembolism and Antithrombotic Therapy in Pregnancy
Chan, W., Rey, É., Kent, N., Chan, W., Kent, N., Rey, É., Corbett, T., David, M., Douglas, M. J., Gibson, P., et al. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30569-7 · Cited by 315 · see citing works
Pulmonary embolism in pregnancy
Bourjeily, G. R., Paidas, M. J., Khalil, H., Rosene‐Montella, K., & Rodger, M. A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60996-x · Cited by 312 · see citing works
Management and Long-Term Prognosis of Spontaneous Coronary Artery Dissection
Lettieri, C., Zavalloni, D., Rossini, R., Morici, N., Ettori, F., Leonzi, O., Latib, A., Ferlini, M., Trabattoni, D., Colombo, P., et al. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.03.039 · Cited by 309 · see citing works
Acute Myocardial Infarction in Pregnancy and the Puerperium: A Population-Based Study
Ladner, H. E., Danielsen, B. H., & Gilbert, W. M. (2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000151998.50852.31 · Cited by 305 · see citing works
Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy
Simmons, L., Gillin, A. G., & Jeremy, R. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00966.2001 · Cited by 297 · see citing works
(2022) · Cineca Institutional Research Information System (Tor Vergata University) · doi:10.1161/circulationaha · Cited by 291 · see citing works
Hypertensive Disorders of Pregnancy and Maternal Cardiovascular Disease Risk Factor Development
Stuart, J. J., Tanz, L. J., Missmer, S. A., Rimm, E. B., Spiegelman, D. L., James-Todd, T. M., & Rich-Edwards, J. W. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2740 · Cited by 281 · see citing works
Long-Term Cardiovascular Risks Associated With Adverse Pregnancy Outcomes
Lane‐Cordova, A. D., Khan, S. S., Grobman, W. A., Greenland, P., & Shah, S. J. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.092 · Cited by 275 · see citing works
Wiznitzer, A., Mayer, A., Novack, V., Sheiner, E., Gilutz, H., Malhotra, A., & Novack, L. (2009) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2009.05.032 · Cited by 274 · see citing works
ACOG Committee Opinion No. 762: Prepregnancy counseling
(2019) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000003013 · Cited by 272 · see citing works
Leffert, L. R., Butwick, A. J., Carvalho, B., Arendt, K. W., Bates, S. M., Friedman, A., Horlocker, T. T., Houle, T. T., & Landau, R. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002530 · Cited by 270 · see citing works
D-Dimer Concentrations in Normal Pregnancy: New Diagnostic Thresholds Are Needed
Kline, J. A., Williams, G. W., & Hernandez‐Nino, J. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.044883 · Cited by 250 · see citing works
Hypertension Canada’s 2018 Guidelines for the Management of Hypertension in Pregnancy
Butalia, S., Audibert, F., Côté, A., Firoz, T., Logan, A. G., Magee, L. A., Mundle, W. R., Rey, É., Rabi, D. M., Daskalopoulou, S. S., et al. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.02.021 · Cited by 247 · see citing works
Cardiac risk in pregnant women with rheumatic mitral stenosis
Silversides, C. K., Colman, J. M., Sermer, M., & Siu, S. C. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00339-4 · Cited by 244 · see citing works
Leung, A. N. C., Bull, T., Jaeschke, R., Lockwood, C. J., Boiselle, P. M., Hurwitz, L. M., James, A., McCullough, L. B., Menda, Y., Paidas, M. J., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201108-1575st · Cited by 229 · see citing works
Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis
Silversides, C. K., Colman, J. M., Sermer, M., Farine, D., & Siu, S. C. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00340-0 · Cited by 224 · see citing works
Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations
Gowda, R. M., Khan, I. A., Mehta, N. J., Vasavada, B. C., & Sacchi, T. J. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00601-0 · Cited by 220 · see citing works
Canadian Cardiovascular Society Position Statement on the Management of Thoracic Aortic Disease
Boodhwani, M., Andelfinger, G., Leipsic, J. A., Lindsay, T. F., McMurtry, M. S., Therrien, J., & Siu, S. C. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.02.018 · Cited by 212 · see citing works
van Hagen, I. M., Boersma, E. H., Johnson, M. R., Thorne, S., Parsonage, W. A., Subías, P. E., Leśniak‐Sobelga, A., Irtyuga, O. B., Sorour, K., Taha, N., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.501 · Cited by 189 · see citing works
van Hagen, I. V., Thorne, S., Taha, N., Youssef, G., Elnagar, A., Gabriel, H., Elrakshy, Y., Iung, B., Johnson, M. R., Hall, R., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.032561 · Cited by 183 · see citing works
Diagnosis of Pulmonary Embolism During Pregnancy
Righini, M., Robert‐Ebadi, H., Élias, A., Sanchez, O., Moigne, E. L., Schmidt, J., Gall, C. L., Cornuz, J., Aujesky, D., Roy, P., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-1670 · Cited by 182 · see citing works
Burden of Arrhythmia in Pregnancy
Vaidya, V. R., Arora, S., Patel, N., Badheka, A. O., Patel, N., Agnihotri, K., Billimoria, Z., Turakhia, M. P., Friedman, P. A., Madhavan, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.026681 · Cited by 175 · see citing works
Managing palpitations and arrhythmias during pregnancy
Adamson, D. L., & Nelson‐Piercy, C. (2007) · Postgraduate Medical Journal · doi:10.1136/hrt.2006.098822 · Cited by 170 · see citing works
Maternal and Fetal Outcomes of Anticoagulation in Pregnant Women With Mechanical Heart Valves
Steinberg, Z. L., Domínguez‐Islas, C., Otto, C. M., Stout, K., & Krieger, E. V. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.03.605 · Cited by 167 · see citing works
Li, J., Nguyen, C., Joglar, J. A., Hamdan, M. H., & Page, R. L. (2008) · Clinical Cardiology · doi:10.1002/clc.20326 · Cited by 165 · see citing works
Risk of Pregnancy in Moderate and Severe Aortic Stenosis
Orwat, S., Diller, G., van Hagen, I. M., Schmidt, R., Tobler, D., Greutmann, M., Jonkaitienė, R., Elnagar, A., Johnson, M. R., Hall, R. J. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.07.750 · Cited by 160 · see citing works
Contemporary Management of Arrhythmias During Pregnancy
Enriquez, A. D., Economy, K. E., & Tedrow, U. B. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001517 · Cited by 156 · see citing works
Self-citationSliwa, K. S., Petrie, M. C., Hilfiker‐Kleiner, D., Mebazaa, A., Jackson, A. M., Johnson, M. R., van der Meer, P., Mbakwem, A. C., & Bauersachs, J. K. (2018) · European Journal of Heart Failure · doi:10.1002/ejhf.1178 · Cited by 151 · see citing works
ACOG Committee Opinion No. 764: Medically Indicated Late-Preterm and Early-Term Deliveries
(2019) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000003083 · Cited by 148 · see citing works
Stroke in pregnancy and the puerperium
Treadwell, S. D., Thanvi, B., & Robinson, T. G. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.066167 · Cited by 146 · see citing works
Martillotti, G., Boehlen, F., Robert‐Ebadi, H., Jastrow, N., Righini, M., & Blondon, M. (2017) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13802 · Cited by 144 · see citing works
McDermott, M., Miller, E. C., Rundek, T., Hurn, P. D., & Bushnell, C. (2018) · Stroke · doi:10.1161/strokeaha.117.018416 · Cited by 136 · see citing works
High-Risk Cardiac Disease in Pregnancy
Elkayam, U., Goland, S., Pieper, P. G., & Silversides, C. K. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.050 · Cited by 136 · see citing works
A Red Blood Cell Agglutination d -Dimer Test to Exclude Deep Venous Thrombosis in Pregnancy
Chan, W., Chunilal, S. D., Lee, A. Y. Y., Crowther, M. A., Rodger, M. A., & Ginsberg, J. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-3-200708070-00005 · Cited by 134 · see citing works
Meng, K., Hu, X., Peng, X., & Zhang, Z. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2014.913130 · Cited by 124 · see citing works
Chan, W., Lee, A. S. H., Spencer, F. A., Chunilal, S. D., Crowther, M. A., Wu, W., Johnston, M., Rodger, M. A., & Ginsberg, J. S. (2010) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2010.03783.x · Cited by 124 · see citing works
Goland, S., van Hagen, I. M., Elbaz‐Greener, G., Elkayam, U., Shotan, A., Merz, W. M., Enar, S. Ç., Гайсин, И. Р., Pieper, P. G., Johnson, M. R., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx189 · Cited by 123 · see citing works
Acute Myocardial Infarction During Pregnancy and the Puerperium in the United States
Smilowitz, N. R., Gupta, N., Guo, Y., Zhong, J., Weinberg, C. R., Reynolds, H. R., & Bangalore, S. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.04.019 · Cited by 122 · see citing works
Exercise or other physical activity for preventing pre-eclampsia and its complications
Meher, S., & Duley, L. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005942 · Cited by 121 · see citing works
Aortic Valve and Ascending Aorta Guidelines for Management and Quality Measures: Executive Summary
Svensson, L. G., Adams, D. H., Bonow, R. O., Kouchoukos, N. T., Miller, D. C., O’Gara, P. T., Shahian, D. M., Schaff, H. V., Akins, C. W., Bavaria, J. E., et al. (2013) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.12.027 · Cited by 115 · see citing works
Arterial dissections associated with pregnancy
Nolte, J. E., Rutherford, R. B., Nawaz, S., Rosenberger, A., Speers, W. C., & Krupski, W. C. (1995) · Journal of Vascular Surgery · doi:10.1016/s0741-5214(95)70296-2 · Cited by 113 · see citing works
The Role of Regular Physical Activity in Preeclampsia Prevention
Weissgerber, T. L., Wolfe, L. A., & Davies, G. (2004) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000147627.35139.dc · Cited by 104 · see citing works
Canadian Stroke Best Practice Consensus Statement: Acute Stroke Management during pregnancy
Ladhani, N. N. N., Swartz, R. H., Foley, N. C., Nerenberg, K. A., Smith, E. E., Gubitz, G. J., Dowlatshahi, D. D., Potts, J., Ray, J. G., Barrett, J. F. R., et al. (2018) · International Journal of Stroke · doi:10.1177/1747493018786617 · Cited by 102 · see citing works
Inferior Vena Cava Filters in Pregnancy: A Systematic Review
Harris, S. A., Velineni, R., & Davies, A. H. (2015) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2015.11.024 · Cited by 88 · see citing works
Thrombolysis in pregnancy: a literature review
Gomes, M. S., Guimarães, M., & Montenegro, N. A. M. D. M. (2018) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2018.1434141 · Cited by 87 · see citing works
Davis, M. B., & Walsh, M. N. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.005417 · Cited by 84 · see citing works
Imaging for the exclusion of pulmonary embolism in pregnancy
van Mens, T. E., Scheres, L. J. J., de Jong, P. G., Leeflang, M., Nijkeuter, M., & Middeldorp, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011053.pub2 · Cited by 82 · see citing works
Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis
Silvis, S. M., Lindgren, E., Hiltunen, S., Devasagayam, S., Scheres, L. J. J., Jood, K., Zuurbier, S. M., Kleinig, T. J., Silver, F. L., Mandell, D. M., et al. (2019) · Stroke · doi:10.1161/strokeaha.118.023017 · Cited by 81 · see citing works
Planned vaginal delivery and cardiovascular morbidity in pregnant women with heart disease
Easter, S. R., Rouse, C. E., Duarte, V. E., Hynes, J. S., Singh, M. N., Landzberg, M. J., Valente, A. M., & Economy, K. E. (2019) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2019.07.019 · Cited by 80 · see citing works
Self-citationEndovascular Imaging of Angiographically Invisible Spontaneous Coronary Artery Dissection
Alfonso, F., Paulo, M., & Dutary, J. (2012) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2012.01.016 · Cited by 78 · see citing works
A negative D-dimer does not exclude venous thromboembolism (VTE) in pregnancy
To, M., Hunt, B. J., & Nelson‐Piercy, C. (2008) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443610801915975 · Cited by 75 · see citing works
Goodacre, S. W., Horspool, K., Nelson‐Piercy, C., Knight, M., Shephard, N., Lecky, F. E., Thomas, S., Hunt, B. J., & Fuller, G. W. (2018) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15286 · Cited by 74 · see citing works
Hedengran, K. K., Andersen, M. R., Stender, S., & Szecsi, P. B. (2016) · Obstetrics and Gynecology International · doi:10.1155/2016/3561675 · Cited by 73 · see citing works
Kline, J. A., Richardson, D. M., Than, M. P., Penaloza, A., & Roy, P. (2014) · Academic Emergency Medicine · doi:10.1111/acem.12471 · Cited by 70 · see citing works
Measures to Reduce Radiation in a Modern Cardiac Catheterization Laboratory
Agarwal, S., Parashar, A., Ellis, S. G., Heupler, F. A., Lau, E., Tuzcu, E. M., & Kapadia, S. R. (2014) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.114.001499 · Cited by 65 · see citing works
Ablation of Incessant Left Atrial Tachycardia Without Fluoroscopy in a Pregnant Woman
Ferguson, J., Helms, A. S., Mangrum, J. M., & Dimarco, J. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01847.x · Cited by 59 · see citing works
van der Pol, L. M., Mairuhu, A. T. A., Tromeur, C., Couturaud, F., Huisman, M. V., & Klok, F. A. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.09.003 · Cited by 56 · see citing works
Pregnancy After Spontaneous Coronary Artery Dissection: A Case Series
Tweet, M. S., Hayes, S. N., Gulati, R., Rose, C. H., & Best, P. J. M. (2015) · Annals of Internal Medicine · doi:10.7326/l14-0446 · Cited by 51 · see citing works
Wolff-Parkinson-White syndrome in pregnancy
Gleicher, N., Meller, J., Sandler, R. Z., & Sullum, S. (1983) · Journal of Emergency Medicine · doi:10.1016/0736-4679(83)90015-x · Cited by 49 · see citing works
Langlois, É., Cusson‐Dufour, C., Moumneh, T., Élias, A., Meyer, G., Lacut, K., Schmidt, J., Gall, C. L., Chauleur, C., Glauser, F., et al. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14483 · Cited by 49 · see citing works
Canadian stroke best practice consensus statement: Secondary stroke prevention during pregnancy
Swartz, R. H., Ladhani, N. N. N., Foley, N. C., Nerenberg, K. A., Bal, S. S., Barrett, J. F. R., Bushnell, C., Chan, W., Chari, R. S., Dowlatshahi, D. D., et al. (2017) · International Journal of Stroke · doi:10.1177/1747493017743801 · Cited by 47 · see citing works
Emergency Evaluation for Pulmonary Embolism, Part 1: Clinical Factors that Increase Risk
Kline, J. A., & Kabrhel, C. (2015) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2014.12.040 · Cited by 45 · see citing works
ACOG Practice Bulletin No. 196 Summary: Thromboembolism in Pregnancy
(2018) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000002707 · Cited by 42 · see citing works
Preconception and Prenatal Radiation Exposure: Health Effects and Protective Guidance
Brent, R. L., Frush, D. P., Harms, R. W., & Linet, M. S. (2013) · The Medicine Forum · Cited by 41 · see citing works
Acute Therapy of Maternal and Fetal Arrhythmias During Pregnancy
Trappe, H. (2006) · Journal of Intensive Care Medicine · doi:10.1177/0885066606291433 · Cited by 40 · see citing works
Yeo, S., & Davidge, S. T. (2001) · Journal of Women s Health & Gender-Based Medicine · doi:10.1089/152460901317193558 · Cited by 38 · see citing works
Ischaemic heart disease and pregnancy
Cauldwell, M., Baris, L., Roos‐Hesselink, J. W., & Johnson, M. R. (2018) · Heart · doi:10.1136/heartjnl-2018-313454 · Cited by 38 · see citing works
Lameijer, H., Burchill, L. J., Baris, L., Ruys, T. P. E., Roos‐Hesselink, J. W., Mulder, B. J. M., Silversides, C. K., van Veldhuisen, D. J., & Pieper, P. G. (2019) · Heart · doi:10.1136/heartjnl-2018-314364 · Cited by 37 · see citing works
Emergency Evaluation for Pulmonary Embolism, Part 2: Diagnostic Approach
Kline, J. A., & Kabrhel, C. (2015) · Journal of Emergency Medicine · doi:10.1016/j.jemermed.2014.12.041 · Cited by 36 · see citing works
Management of stroke and pregnancy
Cauldwell, M., Rudd, A. G., & Nelson‐Piercy, C. (2018) · European Stroke Journal · doi:10.1177/2396987318769547 · Cited by 32 · see citing works
Low Exposure Radiation with Conventional Guided Radiofrequency Catheter Ablation in Pregnant Women
Berruezo, A., DÍEZ, G. R., Berne, P., ESTEBAN, M., Mont, L., & Brugada, J. (2007) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2007.00858.x · Cited by 31 · see citing works
Zhu, D., Zhao, P., Lv, N., Li, Q., Fang, Y., Li, Z., Zhang, H., Duan, G., Hong, B., Xu, Y., et al. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.12.056 · Cited by 31 · see citing works
Lameijer, H., van Slooten, Y. J., Jongbloed, M. R. M., Oudijk, M. A., Kampman, M. A. M., van Dijk, A. P. J., Post, M. C., Mulder, B. J. M., Sollie, K. M., van Veldhuisen, D. J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.05.038 · Cited by 27 · see citing works
Pharmacotherapeutic strategies for atrial fibrillation in pregnancy
Georgiopoulos, G. A., Tsiachris, D., Kordalis, A., Kontogiannis, C., Spartalis, Μ., Pietri, P., Magkas, N., & Stefanadis, C. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1621290 · Cited by 22 · see citing works
Less-Tight Versus Tight Control of Hypertension in Pregnancy
Magee, L. A., von Dadelszen, P., Rey, É., Ross, S., Asztalos, E. V., Murphy, K. E., Menzies, J., Sanchez, J., Singer, J., Gafni, A., et al. (2015) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000202 · Cited by 20 · see citing works
Ventricular Tachycardia in Pregnant Patients
Kotchetkov, R., Patel, A., & Salehian, O. (2010) · Clinical Medicine Insights Cardiology · doi:10.4137/cmc.s4755 · Cited by 17 · see citing works
Choi, H. J., & Krishnamoorthy, D. (2018) · International Journal of Emergency Medicine · doi:10.1186/s12245-018-0169-8 · Cited by 16 · see citing works
Use of adenosine for pharmacological cardioversion of SVT in pregnancy
Chakhtoura, N. A., Angioli, R., & Yasin, S. Y. (1998) · Primary Care Update for OB/GYNS · doi:10.1016/s1068-607x(98)00040-7 · Cited by 11 · see citing works
Massive Hemorrhage Following Thrombolysis for Postpartum Pulmonary Embolism With Cardiac Arrest
Shaulov, T., David, M., Pellerin, M., & Morin, F. (2014) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30563-6 · Cited by 11 · see citing works
Pregnancy in hypertrophic cardiomyopathy
OWENS, A. T. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx304 · Cited by 7 · see citing works
What Is the Best Imaging Study to Rule Out Pulmonary Embolism in Pregnancy?
Ganti, L., & Lebowitz, D. C. (2018) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2018.05.007 · Cited by 1 · see citing works
Flagged first, then by citations
1 of the 145 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- [11]11. ACOG Practice Bulletin No. 202: gestational hypertension and preeclamp- sia. Obstet Gynecol. 2019;133:e1-e25.
- [15]15. Martin JA, Hamilton BE, Osterman MJK, Driscoll AK, Drake P. Births: final data for 2017. Natl Vital Stat Rep. 2018;67:1-50.
- [77]77. Thorne S. Risks of contraception and pregnancy in heart disease. Heart. 2006;92:1520-1525.
Cited by
Sorted by citations
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922 · see citing works
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,301 · see citing works
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862 · see citing works
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization
Lawton, J. S., Tamis‐Holland, J. E., Bangalore, S., Bates, E., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.09.006 · Cited by 1,651 · see citing works
Self-citationVirani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598 · see citing works
Lawton, J. S., Tamis-Holland, J. E., Bangalore, S., Bates, E. R., Beckie, T. M., Bischoff, J. M., Bittl, J. A., Cohen, M. G., DiMaio, J. M., Don, C. W., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001038 · Cited by 1,328 · see citing works
Self-citationPreeclampsia—Pathophysiology and Clinical Presentations
Ives, C. W., Sinkey, R. G., Rajapreyar, I. N., Tita, A., & Oparil, S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.014 · Cited by 934 · see citing works
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596 · see citing works
Lyon, A. R., López‐Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J. K., Boriani, G., Cardinale, D. M., Córdoba, R., Cosyns, B., et al. (2022) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeac106 · Cited by 531 · see citing works
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A. D., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001285 · Cited by 420 · see citing works
Menopause: a cardiometabolic transition
Nappi, R. E., Chedraui, P., Lambrinoudaki, I. V., & Simoncini, T. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00076-6 · Cited by 277 · see citing works
Thompson, A., Fleischmann, K. E., Smilowitz, N. R., Fuentes, L. D. L., Mukherjee, D., Aggarwal, N. R., Ahmad, F. S., Allen, R. B., Altin, S. E., Auerbach, A. D., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.013 · Cited by 251 · see citing works
Lewey, J., Beckie, T. M., Brown, H. L., Brown, S. D., Garovic, V. D., Khan, S. S., Miller, E. C., Sharma, G., Mehta, L. S., & on behalf of the American Heart Association Cardiovascular Disease and Stroke in Women and Underrepresented Populations Committee of the Council on Clinical Cardiology; Council on Cardiopulmonary, C. C. (2024) · Circulation · doi:10.1161/cir.0000000000001212 · Cited by 229 · see citing works
Self-citation2023 Chinese guideline for lipid management
Li, J., Zhao, S., Zhao, D. H., Lü, G., Peng, D., Liu, J., Chen, Z., Guo, Y., Wu, N., Yan, S.-K., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1190934 · Cited by 227 · see citing works
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Circulation Journal · doi:10.1253/circj.cj-25-0002 · Cited by 227 · see citing works
Mehta, L. S., Velarde, G., Lewey, J., Sharma, G. V., Bond, R. M., Navas‐Acién, A., Fretts, A. M., Magwood, G., Yang, E., Blumenthal, R. S., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001139 · Cited by 193 · see citing works
Self-citationSex Differences and Similarities in Valvular Heart Disease
DesJardin, J. T., Chikwe, J., Hahn, R. T., Hung, J., & Delling, F. N. (2022) · Circulation Research · doi:10.1161/circresaha.121.319914 · Cited by 189 · see citing works
Davis, M. B., Arendt, K. W., Bello, N. A., Brown, H. L., Briller, J. E., Epps, K., Hollier, L. M., Langen, E. S., Park, K. E., Walsh, M. N., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.02.033 · Cited by 188 · see citing works
Self-citation2023 HRS expert consensus statement on the management of arrhythmias during pregnancy
Joglar, J. A., Kapa, S., Saarel, E. V., Dubin, A. M., Görenek, B., Hameed, A. B., de Melo, S. L., Leal, M. A., Mondesert, B. A., Pacheco, L. D., et al. (2023) · Heart Rhythm · doi:10.1016/j.hrthm.2023.05.017 · Cited by 165 · see citing works
Mehta, L. S., Sharma, G. V., Creanga, A. A., Hameed, A. B., Hollier, L. M., Johnson, J. C., Leffert, L. R., McCullough, L. D., Mujahid, M. S., Watson, K. E., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001000 · Cited by 136 · see citing works
Self-citation2025 ACC/AHA/HRS/ISACHD/SCAI Guideline for the Management of Adults With Congenital Heart Disease
Gurvitz, M. Z., Krieger, E. V., Fuller, S., Davis, L. L., Kittleson, M. M., Aboulhosn, J., Bradley, E. A., Buber, J., Daniels, C. J., Dimopoulos, K., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.09.006 · Cited by 132 · see citing works
Self-citationCardio-Oncology and Heart Failure: a Scientific Statement From the Heart Failure Society of America
Bloom, M. W., Vo, J. B., Rodgers, J. E., FERRARI, A. M., Nohria, A., Deswal, A. M., Cheng, R. K.-H., Kittleson, M. M., Upshaw, J. N., Palaskas, N. L., et al. (2024) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2024.08.045 · Cited by 120 · see citing works
Meng, M., Arendt, K. W., Banayan, J. M., Bradley, E. A., Vaught, A. “. J., Hameed, A. B., Harris, J., Bryner, B. S., & Mehta, L. S. (2023) · Circulation · doi:10.1161/cir.0000000000001121 · Cited by 117 · see citing works
Self-citation2023 China Guidelines for Lipid Management
Li, J., Zhao, S., Zhao, D., Lü, G., Peng, D., Liu, J., Chen, Z., Guo, Y., Wu, N., Yan, S.-K., et al. (2023) · 老年心脏病学杂志：英文版 · doi:10.26599/1671-5411.2023.09.008 · Cited by 116 · see citing works
Obstetric Anesthesia and Heart Disease: Practical Clinical Considerations
Meng, M., & Arendt, K. W. (2021) · Anesthesiology · doi:10.1097/aln.0000000000003833 · Cited by 95 · see citing works
Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools
Adedinsewo, D. A., Pollak, A. W., Phillips, S. D., Smith, T. L., Svatikova, A., Hayes, S. N., Mulvagh, S. L., Norris, C., Roger, V. L., Noseworthy, P. A., et al. (2022) · Circulation Research · doi:10.1161/circresaha.121.319876 · Cited by 92 · see citing works
Ndumele, C. E., Rodriguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M., Bangalore, S., Bozkurt, B., Breathett, K., Clarke, S. L., et al. (2026) · JACC · doi:10.1016/j.jacc.2026.03.056 · Cited by 90 · see citing works
Pre-Pregnancy Hypertension Among Women in Rural and Urban Areas of the United States
Cameron, N. A., Molsberry, R. J., Pierce, J. B., Perak, A. M., Grobman, W. A., Allen, N. B., Greenland, P., Lloyd‐Jones, D. M., & Khan, S. S. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.09.601 · Cited by 88 · see citing works
Hyperlipidemia and risk for preclampsia
Poornima, I. G., Indaram, M. B., Ross, J. D., Agarwala, A., & Wild, R. A. (2022) · Journal of clinical lipidology · doi:10.1016/j.jacl.2022.02.005 · Cited by 85 · see citing works
ACC/AHA/HFSA 2022 and ESC 2021 Guidelines on Heart Failure Comparison
Behnoush, A. H., Khalaji, A., Naderi, N., Ashraf, H., & von Haehling, S. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14255 · Cited by 85 · see citing works
Ndumele, C. E., Rodríguez, F., Dixon, D. L., Khan, S. S., Mukherjee, D., Bajaj, M. S., Bangalore, S., Bozkurt, B., Breathett, K. K., Clarke, S. L., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001453 · Cited by 87 · see citing works
Cardiovascular Care for Pregnant Women With Cardiovascular Disease
Magun, E., DeFilippis, E. M., Noble, S. C., LaSala, A. P., Waksmonski, C. A., D’Alton, M. E., & Haythe, J. H. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.071 · Cited by 80 · see citing works
Dyslipidaemia management in pregnant patients: a 2024 update
Lewek, J., Bielecka-Dabrowa, A. M., Toth, P. P., & Banach, M. (2024) · European Heart Journal Open · doi:10.1093/ehjopen/oeae032 · Cited by 74 · see citing works
Reproductive health after thoracic transplantation: An ISHLT expert consensus statement
Kittleson, M. M., DeFilippis, E. M., Bhagra, C., Casale, J. P., Cauldwell, M., Coscia, L. A., D'Souza, R. D., Gaffney, N., Gerovasili, V., Ging, P., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.10.009 · Cited by 65 · see citing works
Prevalence, trends, and outcomes of cardiovascular diseases in pregnant patients in the USA: 2010–19
Majmundar, M. M., Doshi, R. P., Patel, K. N., Zala, H. S., Kumar, A., & Kalra, A. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac669 · Cited by 64 · see citing works
Pregnancy-Associated Myocardial Infarction
Tweet, M. S., Lewey, J., Smilowitz, N. R., Rose, C. H., & Best, P. J. M. (2020) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.120.008687 · Cited by 63 · see citing works
Cardiovascular adverse events in pregnancy: A global perspective
Kotit, S., & Yacoub, M. H. (2021) · Global Cardiology Science and Practice · doi:10.21542/gcsp.2021.5 · Cited by 63 · see citing works
Eke, A. C., Gebreyohannes, R. D., Fernandes, M. F. S., & Pillai, V. C. (2023) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2227 · Cited by 59 · see citing works
Agarwala, A., Dixon, D. L., Gianos, E., Kirkpatrick, C. F., Michos, E. D., Satish, P., Birtcher, K. K., Braun, L. T., Pillai, P., Watson, K., et al. (2024) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2024.05.005 · Cited by 57 · see citing works
Self-citationBright, R. A., Lima, F. V., Avila, C., Butler, J., & Stergiopoulos, K. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.021019 · Cited by 56 · see citing works
Valvular Heart Disease in Pregnancy
Lewey, J., Andrade, L., & Levine, L. D. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.09.010 · Cited by 53 · see citing works
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure
Kitai, T., Kohsaka, S., Kato, T., Kato, E. T., Sato, K., TERAMOTO, K., Yaku, H., Akiyama, E., Ando, M., Izumi, C., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.02.014 · Cited by 49 · see citing works
Sex and Gender Aspects in Vascular Ageing – Focus on Epidemiology, Pathophysiology, and Outcomes
Seeland, U., Nemcsik, J., Lønnebakken, M. T., Kublickiene, K. R., Schluchter, H., Park, C. M., Pucci, G., Mozos, I. M., & Bruno, R. M. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.07.006 · Cited by 47 · see citing works
Adedinsewo, D. A., Johnson, P. W., Douglass, E. J., Attia, I. Z., Phillips, S. D., GOSWAMI, R. M., Yamani, M. H., Connolly, H. M., Rose, C. H., Sharpe, E. E., et al. (2021) · European Heart Journal - Digital Health · doi:10.1093/ehjdh/ztab078 · Cited by 45 · see citing works
Roh, J. D., Castro, C., Yu, A., Rana, S., Shahul, S. S., Gray, K. J., Honigberg, M. C., Ricke‐Hoch, M., Iwamoto, Y., Yeri, A., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adi0077 · Cited by 44 · see citing works
Self-citationKris-Etherton, P. M., Petersen, K. S., Després, J.-P., Braun, L., de Ferranti, S. D., Furie, K. L., Lear, S. A., Lobelo, F., Morris, P. B., Sacks, F. M., et al. (2021) · Circulation · doi:10.1161/cir.0000000000001014 · Cited by 43 · see citing works
Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025
Rached, F. H., Miname, M. H., Rocha, V. Z., Zimerman, A., Cesena, F. Y., Sposito, A. C., Santos, R. D., Behr, P. E. B., Bianco, H. T., Alves, R. J., et al. (2025) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20250640 · Cited by 45 · see citing works
Echocardiography for the Pregnant Heart
Afari, H. A., Davis, E., & Sarma, A. A. (2021) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-021-00930-5 · Cited by 41 · see citing works
Management of acute cardiovascular complications in pregnancy
Assenza, G. E., Dimopoulos, K., Budts, W., Donti, A., Economy, K. E., Gargiulo, G., Gatzoulis, M. Α., Landzberg, M. J., Valente, A. M., & Roos‐Hesselink, J. W. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab546 · Cited by 41 · see citing works
Self-citationWindram, J. D., Grewal, J., Bottega, N. A., Sermer, M., SPEARS, D. A., Swan, L., Siu, S. C., & Silversides, C. K. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.06.021 · Cited by 40 · see citing works
Gurvitz, M. Z., Krieger, E. V., Fuller, S., Davis, L. L., Kittleson, M. M., Aboulhosn, J., Bradley, E. A., Buber, J., Daniels, C. J., Dimopoulos, K., et al. (2025) · Circulation · doi:10.1161/cir.0000000000001402 · Cited by 37 · see citing works
Self-citationThe Fourth Trimester: a Time for Enhancing Transitions in Cardiovascular Care
Choi, E., Kazzi, B. E., Varma, B., Ortengren, A. R., Minhas, A., Vaught, A. “. J., Bennett, W. L., Lewey, J., & Michos, E. D. (2022) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-022-00706-x · Cited by 37 · see citing works
Long‐Term Cardiovascular Outcomes After Pregnancy in Women With Heart Disease
Siu, S. C., Lee, D. S., Rashid, M. K., Fang, J., Austin, P. C., & Silversides, C. K. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020584 · Cited by 36 · see citing works
D’Antonio, F., Khalil, A. A., Rizzo, G., Fichera, A., Herrera, M., Buca, D. I. P., Morelli, R., Cerra, C., Orabona, R., Martellucci, C. A., et al. (2022) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2022.100803 · Cited by 35 · see citing works
Briller, J. E., Mogos, M. F., Muchira, J. M., & Piano, M. R. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.12.020 · Cited by 35 · see citing works
Extracorporeal Membrane Oxygenation for Pregnant and Postpartum Patients
Wong, M. J., Bharadwaj, S., Galey, J. L., Lankford, A. S., Galvagno, S., & Kodali, B. S. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005861 · Cited by 34 · see citing works
Worldwide variation in cardiovascular magnetic resonance practice models
Sierra-Galán, L. M., Estrada-Lopez, E. E. S., Ferrari, V. A., Raman, S. V., Ferreira, V. M., Raj, V., Joseph, E., Schulz‐Menger, J., Chan, C., Chen, S. S. M., et al. (2023) · Journal of Cardiovascular Magnetic Resonance · doi:10.1186/s12968-023-00948-7 · Cited by 33 · see citing works
Ogunwole, S. M., Chen, X., Mitta, S., Minhas, A., Sharma, G. V., Zakaria, S., Vaught, A. “. J., Toth‐Manikowski, S. M., & Smith, G. N. (2021) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2021.08.004 · Cited by 33 · see citing works
Self-citationPregnancy after Heart Transplantation
DeFilippis, E. M., & Kittleson, M. M. (2020) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2020.07.011 · Cited by 32 · see citing works
Perfil Epidemiológico da Mortalidade Materna por Síndromes Hipertensivas Gestacionais
Santos, I. D. M., & Almeida-Santos, M. A. (2023) · Research Society and Development · doi:10.33448/rsd-v12i4.41307 · Cited by 30 · see citing works
Leszek, P., Klotzka, A., Bartuś, S., Burchardt, P., Czarnecka, A. M., Długosz‐Danecka, M., Gierlotka, M. J., Koseła-Paterczyk, H., Krawczyk‐Ożóg, A., Kubiatowski, T., et al. (2023) · Kardiologia Polska · doi:10.33963/v.kp.96840 · Cited by 30 · see citing works
Posicionamento sobre Exercícios Físicos na Gestação e no Pós-Parto – 2021
Campos, M. D. S. B., Buglia, S., Colombo, C. S. S. D. S., Büchler, R. D. D., de Brito, A. S. X., Mizzaci, C. C., Feitosa, R. H. F., Leite, D. B., Hossri, C. A. C., de Albuquerque, L. C. A., et al. (2021) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210408 · Cited by 29 · see citing works
Bello, N. A., Agrawal, A., Davis, M. B., Harrington, C. M., Lindley, K. J., Minissian, M. B., Sharma, G. V., Walsh, M. N., & Park, K. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024229 · Cited by 29 · see citing works
Self-citationImaging of heart disease in women: review and case presentation
Mikaïl, N., Rossi, A., Bengs, S., Haider, A., Stähli, B. E., Portmann, A., Impériale, A., Treyer, V., Meisel, A., Pazhenkottil, A. P., et al. (2022) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-022-05914-6 · Cited by 29 · see citing works
Thromboembolism in peripartum cardiomyopathy: a systematic review
Radakrishnan, A., Dokko, J., Pastena, P., & Kalogeropoulos, A. P. (2024) · Journal of Thoracic Disease · doi:10.21037/jtd-23-945 · Cited by 27 · see citing works
Cardio-Obstetrics: the Next Frontier in Cardiovascular Disease Prevention
Thakkar, A., Hailu, T., Blumenthal, R. S., Martin, S. S., Harrington, C. M., Yeh, D. D., French, K. A., & Sharma, G. V. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01026-6 · Cited by 26 · see citing works
Self-citationMaternal Morbidity and Mortality: Are We Getting to the “Heart” of the Matter?
Varagić, J., Desvigne-Nickens, P. M., Gamble‐George, J., Hollier, L. M., Maric‐Bilkan, C., Mitchell, M., Pemberton, V. L., & Redmond, N. (2020) · Journal of Women s Health · doi:10.1089/jwh.2020.8852 · Cited by 25 · see citing works
Pregnancy-Associated Myocardial Infarction: A Review of Current Practices and Guidelines
Alameh, A., Jabri, A., Aleyadeh, W., Nasser, F., Al‐Abdouh, A., Kondapaneni, M. D., Gulati, M., Mattina, D. J., Singh, K., Hargrave, J. M., et al. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01579-z · Cited by 25 · see citing works
Trends in the Incidence and Risk Factors of Pregnancy-Associated Stroke
Ijäs, P. H. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.833215 · Cited by 25 · see citing works
Cancer Treatment-Related Cardiovascular Toxicity in Gynecologic Malignancies
Parashar, S., Akhter, N., Paplomata, E., Elgendy, I. Y., Upadhyaya, D., Scherrer‐Crosbie, M., Okwuosa, T. M., Sanghani, R. M., Chalas, E., Lindley, K. J., et al. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.02.002 · Cited by 25 · see citing works
Boriani, G., Venturelli, A., Imberti, J. F., Bonini, N., Mei, D. A., & Vitolo, M. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.04.020 · Cited by 25 · see citing works
Enomoto, N., Yamashita, T., Furuta, M., Tanaka, H., Ng, E. S. W., Matsunaga, S., Sakurai, A., Kato, R., Takahashi, S., Takeda, J., et al. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-021-04334-y · Cited by 24 · see citing works
Cardiovascular contributions to dementia: Examining sex differences and female‐specific factors
Alexander, M. W., Paterson, J., Arvanitakis, Z., Black, S. E., Casaletto, K. B., Christakis, M. K., Einstein, G., Galea, L. A. M., Harwood, L., Kirkham, A. A., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70610 · Cited by 23 · see citing works
Steiner, J. M., Lokken, E. M., Bayley, E., Pechan, J., Curtin, A. C., Buber, J., & Albright, C. M. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.08.037 · Cited by 23 · see citing works
Denoble, A. E., Goldstein, S. A., Wein, L. E., Grotegut, C. A., & Federspiel, J. J. (2022) · American Heart Journal · doi:10.1016/j.ahj.2022.04.009 · Cited by 23 · see citing works
Assessment and Prediction of Cardiovascular Contributions to Severe Maternal Morbidity
Thakkar, A., Hameed, A. B., Makshood, M., Gudenkauf, B., Creanga, A. A., Malhamé, I., Grandi, S. M., Thorne, S., D'Souza, R. D., & Sharma, G. V. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100275 · Cited by 23 · see citing works
Self-citationPark, S. M., Lee, S. Y., Jung, M., Youn, J., Kim, D., Cho, J. Y., Cho, D., Hyun, J., Cho, H., Park, S., et al. (2023) · International Journal of Heart Failure · doi:10.36628/ijhf.2023.0016 · Cited by 21 · see citing works
Reproductive milestones across the lifespan and cardiovascular disease risk in women
Stuenkel, C. A. (2023) · Climacteric · doi:10.1080/13697137.2023.2259793 · Cited by 21 · see citing works
Complementary medicines and therapies in clinical guidelines on pregnancy care: A systematic review
Ee, C., Levett, K. M., Smith, C. A., Armour, M., Dahlen, H. G., Chopra, P., Maroun, P., Rao, V. S., Avard, N., Grant, S. J., et al. (2021) · Women and Birth · doi:10.1016/j.wombi.2021.08.003 · Cited by 21 · see citing works
Maternal Cardiovascular Morbidity Events Following Preeclampsia: A Retrospective Cohort Study
Meng, M., Frere, Z., Fuller, M., Li, Y., Habib, A. S., Federspiel, J. J., Wheeler, S. M., Gilner, J. B., Shah, S. H., Ohnuma, T., et al. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000006310 · Cited by 20 · see citing works
Perioperative management of pregnant women undergoing nonobstetric surgery
Aurón, M., Castillo, M. Y. D., & Dueñas-García, O. F. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.88a.18111 · Cited by 20 · see citing works
Shara, N. M., Mirabal‐Beltran, R., Talmadge, B., Falah, N. U., Ahmad, M. F., Dempers, R., Crovatt, S., Eisenberg, S. B., & Anderson, K. M. (2024) · JMIR Cardio · doi:10.2196/53091 · Cited by 19 · see citing works
Animal Models of Cardiovascular Complications of Pregnancy
Arany, Z. P., Hilfiker‐Kleiner, D., & Karumanchi, S. A. (2022) · Circulation Research · doi:10.1161/circresaha.122.320395 · Cited by 19 · see citing works
Cardiovascular Complications of COVID-19 among Pregnant Women and Their Fetuses: A Systematic Review
Yaghoobpoor, S., Fathi, M., Vakili, K. G., Tutunchian, Z., Dehghani, M., Bahrami, A., Hajibeygi, R., Eslami, S., Yaghoobpour, T., & Hajiesmaeili, M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206194 · Cited by 19 · see citing works
Adedinsewo, D. A., Morales-Lara, A. C., Dugan, J. L., Garzon-Siatoya, W. T., Yao, X., Johnson, P. W., Douglass, E. J., Attia, Z. I., Phillips, S. D., Yamani, M. H., et al. (2023) · American Heart Journal · doi:10.1016/j.ahj.2023.03.008 · Cited by 19 · see citing works
Preeclampsia: Etiology, Pathophysiology, Risk Factors, Impact and Prevention: A Narrative Review
Mustary, M., Ansariadi, A., Syam, A., Riskiyani, S., Erika, K. A., Moedjiono, A. I., & Lubis, M. (2024) · Iranian Journal of Public Health · doi:10.18502/ijph.v53i11.16941 · Cited by 19 · see citing works
Sierra-Galán, L. M., Bhatia, M., Alberto-Delgado, A. L., Madrazo-Shiordia, J. A., Salcido-Carmona, C. A., Santoyo, B., Martinez, E., & Soto, M. E. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.870200 · Cited by 18 · see citing works
Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review
Girolamo, R. D., Alameddine, S., Khalil, A. A., Santilli, F., Rizzo, G., Maruotti, G. M., Liberati, M., & D’Antonio, F. (2022) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2022.12.032 · Cited by 18 · see citing works
Rakisheva, A., Sliwa, K. S., Bauersachs, J. K., Linthout, S. V., Chopra, V., Bayés‐Genís, A., Fruzzetti, F., Cannata, A. N., Deniau, B., Mebazaa, A., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3246 · Cited by 18 · see citing works
Interventional Cardiac Procedures and Pregnancy
Park, K. E., Bortnick, A. E., Lindley, K. J., Sintek, M. A., Sethi, S. S., Choi, C., Davis, M. B., Walsh, M. N., Voeltz, M. D., Bello, N. A., et al. (2022) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2022.100427 · Cited by 17 · see citing works
Garcia, J. E., Mulrenin, I. R., Nguyen, A. B., Loop, M. S., Daubert, M. A., Urrutia, R. P., & Lee, C. R. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1225251 · Cited by 17 · see citing works
Acute Coronary Syndrome in Pregnancy and the Post-Partum Period
O’Kelly, A. C., Ludmir, J., & Wood, M. J. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9070198 · Cited by 17 · see citing works
Self-citationRex, S., & Devroe, S. (2022) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2022.02.005 · Cited by 16 · see citing works
Assessing the dyslipidemias: to fast or not to fast?
Farukhi, Z. M., & Mora, S. (2021) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000615 · Cited by 16 · see citing works
Mulrenin, I. R., Garcia, J. E., Fashe, M. M., Loop, M. S., Daubert, M. A., Urrutia, R. P., & Lee, C. R. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.2002845 · Cited by 16 · see citing works
Substance Use in Pregnancy and its Association With Cardiovascular Events
Evans, K., Wu, P., Mamas, M. A., Irwin, C., Kang, P. T., Perlow, J. H., Foley, M., & Gulati, M. (2023) · JACC Advances · doi:10.1016/j.jacadv.2023.100619 · Cited by 16 · see citing works
Pregnancy, aortic events, and neonatal and maternal outcomes
Chen, S., Chang, F., Chen, C.-Y., Cheng, Y.-T., Hsiao, F., Tung, Y., Lin, C., Wu, V. C., Chu, P., & Chou, A. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae757 · Cited by 16 · see citing works
Ghelfi, A. M., Ferretti, M. V., & Staffieri, G. J. (2021) · Hipertensión y Riesgo Vascular · doi:10.1016/j.hipert.2021.01.002 · Cited by 16 · see citing works
Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease
Thobani, A., Hassen, L. J., Mehta, L. S., & Agarwala, A. (2021) · Current Atherosclerosis Reports · doi:10.1007/s11883-021-00957-w · Cited by 16 · see citing works
Self-citationReproductive Health in Congenital Heart Disease: Preconception, Pregnancy, and Postpartum
Halpern, D. G., Penfield, C. A., Feinberg, J. L., & Small, A. J. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10050186 · Cited by 15 · see citing works
- Authors
- Mehta, L. S., Warnes, C. A., Bradley, E., Burton, T., Economy, K., Mehran, R., Safdar, B., Sharma, G., Wood, M., Valente, A. M., Volgman, A. S., & On behalf of the American Heart Association Council on Clinical Cardiology; Council on Arteriosclerosis, T. A. V. B. C. O. C. A. S. N. A. S. C.
- ORCID
- Venue
- Circulation
- Published
- 2020-06-09
- Volume
- 141
- Issue
- 23
- Pages
- e884-e903
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W3022591273
- Semantic Scholar
- a4f99c537a938a755723900351845a99644d8796
- Cited by
- 464
- References
- 145
- Citations by year
- 2026: 96 · 2025: 69 · 2024: 70 · 2023: 81 · 2022: 75 · 2021: 56 · 2020: 17
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Update notices
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Issues in Pregnancy
- Health Sciences › Medicine › Obstetrics and Gynecology › Pregnancy and preeclampsia studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- cardiovascular disease in pregnancy, cardio-obstetrics, maternal mortality, hypertensive disorders of pregnancy, preeclampsia, hypercholesterolemia, myocardial infarction, cardiomyopathy, cardiac arrhythmias, valvular heart disease, thromboembolism, aortic disease, cerebrovascular disease, preconception counseling, maternal morbidity, postpartum care
- MeSH terms
- American Heart Association, Female, Humans, Postnatal Care, Pregnancy, Pregnancy Complications, Cardiovascular, United States, Delivery, Obstetric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
